100
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis

, , , , , , & show all
Pages 513-518 | Published online: 09 Mar 2017

References

  • World Health OrganizationAtlas multiple sclerosis resources in the world 2008GenevaWHO Press2008
  • CompstonAColesAMultiple sclerosisLancet200837296481502151718970977
  • NoseworthyJHLucchinettiCRodriguezMWeinshenkerBGMultiple sclerosisN Engl J Med20003431393895211006371
  • WeinshenkerBGBassBRiceGPThe natural history of multiple sclerosis: a geographically based study. I. Clinical course and disabilityBrain1989112pt 11331462917275
  • SadovnickADEbersGCWilsonRWPatyDWLife expectancy in patients attending multiple sclerosis clinicsNeurology19924259919941579256
  • ScalfariAKnappertzVCutterGGoodinDSAshtonREbersGCMortality in patients with multiple sclerosisNeurology201381218419223836941
  • GoodinDSFrohmanEMGarmanyGPJrDisease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice GuidelinesNeurology200258216917811805241
  • MenzinJCaonCNicholsCWhiteLAFriedmanMPillMWNarrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJ Manag Care Pharm2013191 suppl AS24S4023383731
  • TurnerAPWilliamsRMSloanAPHaselkornJKInjection anxiety remains a long-term barrier to medication adherence in multiple sclerosisRehabil Psychol200954111612119618711
  • DiMatteoMRLepperHSCroghanTWDepression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceArch Intern Med2000160142101210710904452
  • BruceJMHancockLMArnettPLynchSTreatment adherence in multiple sclerosis: association with emotional status, personality, and cognitionJ Behav Med201033321922720127401
  • BeerKMullerMHew-WinzelerAMThe prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational studyBMC Neurol20111114422074056
  • SteinbergSCFarisRJChangCFChanATankersleyMAImpact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort studyClin Drug Investig201030289100
  • TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
  • MeynielCSpelmanTJokubaitisVGCountry, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndromePLoS One201276e3866122768046
  • BowlbyJAttachment and LossNew York, NYBasic Books1969
  • HunterJJMaunderRGUsing attachment theory to understand illness behaviorGen Hosp Psychiatry200123417718211543843
  • SockalingamSBlankDAbdelhamidNAbbeySEHirschfieldGMIdentifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factorsJ Hepatol20125761299130422871503
  • SockalingamSCassinSHawaRPredictors of post-bariatric surgery appointment attendance: the role of relationship styleObes Surg201323122026203223757051
  • CiechanowskiPRussoJKatonWInfluence of patient attachment style on self-care and outcomes in diabetesPsychosom Med200466572072815385697
  • CiechanowskiPRussoJKatonWJRelationship styles and mortality in patients with diabetesDiabetes Care201033353954420007946
  • SvarstadBLChewningBASleathBLClaessonCThe Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherencePatient Educ Couns199937211312414528539
  • KroenkeKSpitzerRLWilliamsJBThe PHQ-9: validity of a brief depression severity measureJ Gen Intern Med20011660661311556941
  • SpitzerRLKroenkeKWilliamsJBLoweBA brief measure for assessing generalized anxiety disorder: the GAD-7Arch Intern Med20061661092109716717171
  • KroenkeKSpitzerRLWilliamsJBWThe PHQ-15: validity of a new measure for evaluating severity of somatic symptomsPsychosom Med200264225826611914441
  • HogeCWMcGurkDThomasJLCoxALEngelCCCastroCAMild traumatic brain injury in U.S. soldiers returning from IraqN Engl J Med2008358545346318234750
  • ShaMCCallahanCMCounsellSRWestmorelandGRStumpTEKroenkeKPhysical symptoms as a predictor of health care use and mortality among older adultsAm J Med2005118330130615745729
  • BrennanKAClarkCLShaverPRSelf-report measurement of adult attachmentSimpsonJARhodesWSAttachment Theory and Close RelationshipsNew York, NYGuildford19884776
  • NasreddineZSPhillipsNABedirianVThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentJ Am Geriatr Soc200553469569915817019
  • TarrantsMOleen-BurkeyMCastelli-HaleyJLageMJThe impact of comorbid depression on adherence to therapy for multiple sclerosisMult Scler Int2011201127132122096632
  • DiMatteoMRHaskardKBWilliamsSLHealth beliefs, disease severity, and patient adherence: a meta-analysisMed Care200745652152817515779
  • MackenzieISMorantSVBloomfieldGAMacDonaldTMO’RiordanJIncidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research DatabaseJ Neurol Neurosurg Psychiatry2014851768424052635